Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1742587
Name of medicinal product: JYLAMVO
Active substances:
Methotrexate
Estonian, English, Latin
ATC code: L01BA01
Dosage form: oral solution
Route of administration: oral use
Strengh: 2mg 1ml
Amount in package: 60ml 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Jylamvo is for use in the following indications: In rheumatological and dermatological diseases - Active rheumatoid arthritis in adult patients - Polyarthritic forms of active, severe juvenile idiopathic arthritis (JIA) in adolescents and children aged 3 years and over when the response to non-steroidal anti-inflammatory drugs (NSAIDs) has been inadequate. - Severe, treatment-refractory, disabling psoriasis which does not respond sufficiently to other forms of treatment such as phototherapy, psoralen and ultraviolet A radiation (PUVA) therapy and retinoids, and severe psoriatic arthritis in adult patients. In oncology - Maintenance treatment of acute lymphoblastic leukaemia (ALL) in adults, adolescents and children aged 3 years and over
Safety features: Yes
Summary of product characteristics (SPC):
Package information leaflet (PIL): EST
Labelling:  
Last imported to Estonia: Never imported to Estonia
Marketing authorization holder: Therakind (Europe) Limited 
Marketing authorization number: EU/1/17/1172 
Marketing authorization issued on: March 31, 2017 
Marketing authorization expires on: Unlimited 
Marketing authorization procedure type: Centralised 
Reference price:   
Under reference price:   
Reference price of daily dose:   
Entry/Changing date: March 18, 2024
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere